Publication | Closed Access

HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit

Metabolic SyndromeCholesterol-fed RabbitOxysterolCardiovascular DiseaseHmg-coa ReductaseMedicinePhysiologyPathologyHyperlipidemiaVascular BiologyPlasma CholesterolPharmacologyAtherosclerosisDyslipidemiaOxidative StressHealth Sciences